JVIM 2019 Flashcards
(406 cards)
Efficacy of Long Term Oral Telmisartan Treatment in Cats with Hypertension
2mg/kg Telmisartan PO q24h was effective in reducing systolic arterial blood pressure in hypertensive cats with BP >160mmHg and <200mmHg
52% of Telmisartan treated cats has BP <150mmHg at end of study
Mean BP reduction by Telmisartan in severe (>180mmHg) and moderate (160-179) was comparable and persistent over time
A Pilot Study Investigating Circulating Trimethylamine N-oxide and Its Precursors in Dogs with Degenerative Mitral Valve Disease with or without congestive heart failure
Increased levels of circulating trimethylamine N-oxide and its precursors choline and L-carnitine are associated with the presence of and severity of heart disease in people
Dogs with CHF secondary to DMVD had higher concentrations of Trimethylamine N-oxide compared to asymptomatic DMVD dogs and healthy controls
More studies are needed to determine role in the development or progression of DMVD or CHF
Evaluation of a High-Sensitivity Cardiac Troponin I Assay Compared to a First-Generation Cardiac Troponin I Assay in Doberman Pinschers with and without dilated cardiomyopathy
High sensitivity cardiac troponin I assay is an additional test with good potential to identify early DCM
Factors Associated with Disease Progression in Dogs with Presumed Preclinical Degenerative Mitral Valve Disease Attending Primary Care Veterinary Practices in the UK
Plasma NT-propBNP, Heart Rate, Heart Murmur Intensity, presence of a cough, being a CKCS, and being prescribed pimobendan were associated with clinical progression to initiation of treatment with a potent diuretic or cardiac related death
Dogs with Stage B DMVD might benefit from more frequent monitoring or further diagnostic evaluation
Prognostic Factors in Dogs with Presumed Degenerative Mitral Valve Disease Attending Primary Care Veterinary Practices in the UK
Dogs with high er NT-proBNP and cTnl concentrations, higher heart rates, older dogs, females, and those reported to be exercise intolerant dyspneic, and diagnosed with selected comorbidites had an increased hazard of death due to any cause
With the addition of heart murmur intensity and receiving diuretics, they had a higher hazard of cardiac related death
LAyer-Specific Myocardial Function in Asymptomatic Cats with Obstructive Hypertrophic Cardiomyopathy Assessed using 2-dimenisional speckle-tracking echocardiography
Differed in asymptomatic cats with obstructive HCM compared to controls despite their apparently normal systolic function, determined by conventional echo.
This may reflect compensation for occult systolic dysfunction in cats with obstructive HCM
Anatomy, Baseline Characteristics, and procedural outcome of PDA in GSD
the majority of GSD in this population had type II PDA anatomy that was amenable to ACDO deployment
Predisposition for large median minimal ductal diameter and occasional unusual PDA anatomy suggests that transesophageal echo may be beneficial in procedural planning
Clinical, Epidemiological, and echo features and prognostics factors in cats with restrictive cardiomyopathy
Cardiac death is common in RCM cats, and LA enlargement seems independently associated with decreased survival time in these cats
Safety and Efficacy of Orally Administrated Telmisartan for the treatment of of systemic hypertension in cats
SBP decreased was significantly larger in Telmisartan treated vs placebo (decreased of 23.9mmHg on day 28)
the decrease in SBP persisted over the 6 month trial period
Use of 2D speckle tracking echo to assess left ventricular systolic function in dogs with systemic inflammatory response syndrome
Speckle tracking X4D-EF and Endo-G-Long-st are more sensitive than 2D and M-mode FS, EF, and ESVI in detecting systolic impairments in digs with SIRS
Long Term Incidence and risk of non cardiovascular and all-cause mortality in apparently healthy cats and cats with preclinical HCM
All case mortality was significantly greater in pHCM cats due to disease burden contributed by increased cardiovascular death superimposed upon non cardiovascular death
Noncardiovascular death occurred in 30.9% of cats. proportion of noncardiovascular death did not differ significantly between cats that were AH or pHCM (p=.48)
Evaluation of a sensitive cardiac troponin I assay as a screening test of the diagnosis of HCM in cats
Cardiac troponin I can be used as a sensitivity and specific screening test for the diagnosis of HCM in otherwise healthy cats (Cutoff >0.06ng/mL)
Echo still needed to confirm
Clinica and lab findings and survival time associated with cardiac cachexia in dogs with CHF
cardiac cachexia is common in dogs with CHF and is associated with significantly shorter survival
On multivaraible analysis, cachexia, clinically important tachyarrythmias, azotemia, and being under or overweight were associated with shorter survival times
Evaluation of benazepril in cats with heart disease in a prospective
Benazepril was tolerated in cats with heart disease, but no evidence of benefit was detected
Plasma and Tissue angiotensive-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease
Median plasma ACE2 activity was significantly increased in dogs with CHF
Plasma equilibrium analysis of RAAS APs identified significant increased in the median concentrations of beneficial APs
ACE2 is a homologue of ACE and produces angiotensin peptides
Use of cardiac ultrasound to screen for occult heart disease in asymptomatic cats
focused cardiac ultrasound performed by nonspecialist practitioners increased the detection of occult heart disease (especially in cats with moderate to marked disease)
speckle tracking echo in cats with preclinical HCM
Cats with preclinical HCM have decreased long axis and radial deformation
Comparison between real time 3D and 2D biplane echo assessment of left atrial volumes in dogs with MMVD
Simpson’s modified method of discs is method of choice
Echo quantization of left heart size and function in 122 healthy dogs
body size independent reference intervals for several linear, area, and volume measurements of LA and LV size and function were generated prospectively
Lidocaine for chemical cardioverson of orthodromic AV reciprocating tachycardia in dogs
Lidocaine successfully cardioverted in 84.4% of dogs
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated heart failure caused by MMVD
Rapid absorption of BNP1-32 and a corresponding rise in urinary cyclic guanosine monophosphate excretion was observed at 1-2 hours after any treatments containing BNP1-32
No beneficial caiorenal effects were detected. it is possible that dogs with chronic CHF have a reduction in natriuretic peptide responsiveness
Concurrent pituitary and adrenocortical lesions on computed tomography imagines in dogs with spontaneous hypercortisolism
Concurrent pituitary and adrenal lesions were present in 5% of all dogs with hypercortisolism and in 10% of the dexamethasone resistant dogs
CT angiography and ultrasound in the diagnosis and evaluation of acute pancreatitis in dogs
Compared to US, CTA better identified portal vein thrombosis
Patients with heterogenous contrast enhancement had longer hospitalization (>5 days), had more relapses, and were more likely to have a portal vein thrombosis
CTA was better identified dogs with more severe acute pancreatitis
Behavior in dogs with spontaneous hypothyroidism during treatment with levothyroxine
after 6 weeks of thyroid hormone supplementation, there was a significant increase in activity of hypothyroid dogs
No significant change in behavioral signs after 6 months of treatment
no difference in circulating concentrations of serotonin